Correlation Between Acrivon Therapeutics, and ABVC Biopharma
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and ABVC Biopharma, you can compare the effects of market volatilities on Acrivon Therapeutics, and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and ABVC Biopharma.
Diversification Opportunities for Acrivon Therapeutics, and ABVC Biopharma
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Acrivon and ABVC is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and ABVC Biopharma go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and ABVC Biopharma
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 0.98 times more return on investment than ABVC Biopharma. However, Acrivon Therapeutics, Common is 1.02 times less risky than ABVC Biopharma. It trades about 0.06 of its potential returns per unit of risk. ABVC Biopharma is currently generating about -0.02 per unit of risk. If you would invest 405.00 in Acrivon Therapeutics, Common on August 26, 2024 and sell it today you would earn a total of 250.00 from holding Acrivon Therapeutics, Common or generate 61.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. ABVC Biopharma
Performance |
| Timeline |
| Acrivon Therapeutics, |
| ABVC Biopharma |
Acrivon Therapeutics, and ABVC Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and ABVC Biopharma
The main advantage of trading using opposite Acrivon Therapeutics, and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. HCW Biologics | Acrivon Therapeutics, vs. Scpharmaceuticals | Acrivon Therapeutics, vs. Milestone Pharmaceuticals |
| ABVC Biopharma vs. Indaptus Therapeutics | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Forte Biosciences | ABVC Biopharma vs. Aileron Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |